1例鹦鹉热衣原体肺炎继发CRKP血流感染患者药学监护案例报道  

A case report of pharmaceutical care for a patient with CRKP bloodstream infection secondary to Chlamydia psittaci pneumonia

作　　者：高志英 陈虹[2] 方洁[3] GAO Zhiying;CHEN Hong;FANG Jie(Department of Pharmacy,Ankang People’s Hospital,Ankang 725000,China;Department of Pulmonary and Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Department of Pharmacy,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China)

机构地区：[1]安康市人民医院药学部,安康725000 [2]上海交通大学医学院附属瑞金医院呼吸与危重症医学科,上海200025 [3]上海交通大学医学院附属瑞金医院药剂科,上海200025

出　　处：《上海医药》2023年第23期102-106,共5页Shanghai Medical & Pharmaceutical Journal

摘　　要：目的 :探讨社区获得性鹦鹉热衣原体肺炎继发CRKP血流感染患者抗感染诊疗策略。方法 :临床药师参与1例重症社区获得性鹦鹉热衣原体肺炎继发CRKP血流感染患者的治疗。临床药师在初始给药方案选择、后续治疗方案调整、疗效观察和不良反应监测等方面提出建议并进行药学监护。结果:根据患者病情变化,积极调整抗感染治疗方案,患者感染得到了有效控制,且未出现不良反应。结论 :临床药师参与患者治疗可发挥专业特长,保证药物治疗的安全性和有效性。Objective:To explore the anti-infection diagnosis and treatment strategy for a patient with CRKP bloodstream infection secondary to community acquired Chlamydia psittaci pneumonia.Methods:Clinical pharmacists participated in the treatment of the patient and proposed some suggestions on the selection of initial drug administration regimen,adjustment of subsequent treatment regimen,observation of efficacy and monitoring of adverse reactions.Results:According to the change of the patient’s condition,the anti-infective treatment plan was actively adjusted,and the infection of the patient was effectively con trolled without adverse reactions.Conclusion:Clinical pharmacists can give full play to their professional expertise and ensure the safety and effectiveness of drug therapy when participated in the treatment of patients.

关 键 词：鹦鹉热衣原体 重症肺炎 宏基因组二代测序 

分 类 号：R518.1[医药卫生—内科学] R952[医药卫生—临床医学]